Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
31
days
Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?
Authors
Michael A. Liu; Kyle Miyazaki; Karie Runcie; Hanna Cash; Lingbin MengShow moreShow less
Affiliations
1. Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA; 2. Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, USA; 3. Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, USAShow moreShow less
100
days
Real-World Comparative Effectiveness and Safety of Immune Checkpoint Inhibitors in Advanced Renal Cell Carcinoma: A Systematic Review
Authors
Chin Hang Yiu; Gwyneth Yuet Yin Leung; Isabelle C. Lee; Christine Y. LuShow moreShow less
Affiliations
1. The University of Sydney, School of Pharmacy, Camperdown, Australia; 2. Kolling Institute, Faculty of Medicine and Health, The University of Sydney and the Northern Sydney Local Health District, Sydney, Australia; 3. Department of Pharmacy, Royal North Shore Hospital, St Leonards, AustraliaShow moreShow less
165
days
Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial
Authors
Yu Sunakawa; Hisateru Yasui; Manabu Shiozawa; Hiroyuki Takeda; Naoya Akazawa; Tamotsu Sagawa; Kazuhiro Shiraishi; Takahisa Kyogoku; Takashi Mine; Yasuhiro Yuasa; Takanori Watanabe; Tatsuya Kinjo; Yoshihiro Okita; Hiroyuki Okuyama; Satoshi Yuki; Koki Miyakawa; Ayana Kobara; Shoko Yanaka; Yukiko Abe; Wataru Ichikawa; Masashi Fujii; Akihito TsujiShow moreShow less
Affiliations
1. Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan; 2. Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan; 3. Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan; 4. Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan; 5. Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan; 6. Department of Medical Oncology, NHO Nagoya Medical Center, Nagoya, Japan; 7. Department of Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan; 8. Department of Clinical Oncology, Nagasaki Harbor Medical Center, Nagasaki, Japan; 9. Department of Gastrointestinal Surgery, Tokushima Red Cross Hospital, Tokushima, Japan; 10. Department of Surgery, Japanese Red Cross Society Himeji Hospital, Himeji, Japan; 11. Department of Surgery, Tokushima Municipal Hospital, Tokushima, Japan; 12. Division of Digestive and General Surgery, University of the Ryukyus, Ginowan, Japan; 13. Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan; 14. Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan; 15. Sysmex Corporation, Kobe, Japan; 16. G&G SCIENCE CO., LTD., Fukushima, Japan; 17. Division of Medical Oncology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan; 18. Japan Clinical Cancer Research Organization, Tokyo, JapanShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
